Minutes Of Meetings

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01CE02	IRINOTECAN GP PHARM	G	Irinotecan HCl trihydrate - 100mg/5ml	100mg/5ml	Injectable concentrated solution	5,239,642 L.L
L01CE02	IRINOTECAN GP PHARM	G	Irinotecan HCl trihydrate - 100mg/5ml	100mg/5ml	Injectable concentrated solution	5,239,642 L.L
J06BB01	IMMUNORHO	BioHuman	Human anti-D (rh) immunoglobulin - 300mcg	300mcg	Injectable dry powder+diluent	5,794,649 L.L
J07CA06	INFANRIX IPV + HIB	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	3,014,239 L.L
A02BC01	IPPROTON	G	Omeprazole - 40mg	40mg	Injectable lyophilised powder	6,533,762 L.L
B02BD04	IMMUNINE	BioHuman	Plasma coagulation factor IX, human - 600IU	600IU	Injectable lyophilised powder for solution+diluent	20,506,214 L.L
L04AB02	IXIFI	BioTech	Infliximab - 100mg	100mg	Injectable powder for concentrate for solution	L.L
L04AB02	IXIFI	BioTech	Infliximab - 100mg	100mg	Injectable powder for concentrate for solution	23,911,751 L.L
J01DH51	IMILASTIN	G	Imipenem - 500mg, Cilastatin - 500mg		Injectable powder for solution	5,869,189 L.L
J01DH51	IMIPENEM-CILASTATIN LABATEC	G	Imipenem (monohydrate) - 500mg, Cilastatin (sodium) - 500mg		Injectable powder for solution	8,922,845 L.L
J01DH51	IMIPENEME CILASTATINE PANPHARMA	G	Imipenem (monohydrate) - 500mg, Cilastatin (sodium) - 500mg		Injectable powder for solution	10,840,366 L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 10g/200ml	10g/200ml	Injectable solution	53,767,929 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	190,826 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	L.L
J06BA02	IG VENA	BioHuman	Human normal immunoglobulin - 1g/20ml	1g/20ml	Injectable solution	7,474,948 L.L
J06BB04	IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB	BioHuman	Hepatitis B immunoglobulin (human) - 100UI/ml	100UI/ml	Injectable solution	6,853,730 L.L
J06BB04	IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB	BioHuman	Hepatitis B immunoglobulin (human) - 500UI/5ml	500UI/5ml	Injectable solution	26,599,935 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 400mg/100ml	400mg/100ml	Injectable solution	231,141 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 200mg/50ml	200mg/50ml	Injectable solution	161,261 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 600mg/100ml	600mg/100ml	Injectable solution	550,975 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	188,772 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	174,553 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	167,780 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	170,630 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	166,708 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	227,939,689 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	227,939,689 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 120mg/2.4ml	120mg/2.4ml	Injectable solution	59,776,110 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 120mg/2.4ml	120mg/2.4ml	Injectable solution	59,776,110 L.L

2018	2019
MoM-MHPSS TF-Beirut-Nov18 MoM-MHPSS TF-Beirut-Oct18 MoM-MHPSS TF-Beirut-Sep18 MoM-MHPSS TF-Beirut-Aug18 MoM-MHPSS TF-Beirut-July18	MoM-MHPSS TF-Beirut-Apr19 MoM-MHPSS TF-Beirut-Mar19 MoM-MHPSS TF-Beirut-Feb19 MoM-MHPSS TF-Beirut-Jan19

2016	2017
MoM-MHPSS TF-Beirut-26-Nov16 MoM-MHPSS TF-Beirut-25-Oct16 MoM-MHPSS TF-Beirut-24-Sep16 MoM-MHPSS TF-Beirut-23-Aug16 MoM-MHPSS TF-Beirut-22-July16 MoM-MHPSS TF-Beirut-20-Apr16 MoM-MHPSS TF-Beirut-19-Mar16 MoM-MHPSS TF-Beirut-18-Feb16 MoM-MHPSS TF-Beirut-17-Jan16	MoM-MHPSS TF-Beirut-9-May17 MoM-MHPSS TF-Beirut-31-July17 MoM-MHPSS TF-Beirut-12-Sep17 MoM-MHPSS TF-Beirut-14-Nov17

2018	2019
MoM-MHPSS TF-Bekaa-Nov18 MoM-MHPSS TF-Bekaa-Oct18 MoM-MHPSS TF-Bekaa-Sep18 MoM-MHPSS TF-Bekaa-Aug18 MoM-MHPSS TF-Bekaa-July18 MoM-MHPSS TF-Bekaa-June18	MoM-MHPSS TF-Bekaa-Apr19 MoM-MHPSS TF-Bekaa-Mar19 MoM-MHPSS TF-Bekaa-Feb19 MoM-MHPSS TF-Bekaa-Jan19

2016	2017
MoM-MHPSS TF-Bekaa-20-Dec16 MoM-MHPSS TF-Bekaa-25-Oct16 MoM-MHPSS TF-Bekaa-27-Sep16 MoM-MHPSS TF-Bekaa-01-May16	MoM-MHPSS TF-Bekaa-28 Feb17 MoM-MHPSS TF-Bekaa-24-Jan17

2018	2019
MoM-MHPSS TF-North-Nov18 MoM-MHPSS TF-North-Oct18 MoM-MHPSS TF-North-Sep18 MoM-MHPSS TF-North-Aug18 MoM-MHPSS TF-North-July18	MoM-MHPSS TF-North-Apr19 MoM-MHPSS TF-North-Mar19 MoM-MHPSS TF-North-Feb19 MoM-MHPSS TF-North-Jan19

2015	2016
MoM-MHPSS TF-North-1-Aug15 MoM-MHPSS TF-North-2-Sept15 MoM-MHPSS TF-North-3-Oct15 MoM-MHPSS TF-North-4-Nov15 MoM-MHPSS TF-North-5-Dec15	MoM-MHPSS TF-North-14-Nov16 MoM-MHPSS TF-North-13-Oct16 MoM-MHPSS TF-North-12-Aug16 MoM-MHPSS TF-North-10-June16 MoM-MHPSS TF-North-9-May16 MoM-MHPSS TF-North-8-Mar16 MoM-MHPSS TF-North-7-Feb16 MoM-MHPSS TF-North-6-Jan16

2018	2019
MoM-MHPSS TF-South-Nov18 MoM-MHPSS TF-South-Oct18 MoM-MHPSS TF-South-Sep18 MoM-MHPSS TF-South-Aug18 MoM-MHPSS TF-South-July18	MoM-MHPSS TF-South-Apr19 MoM-MHPSS TF-South-Mar19 MoM-MHPSS TF-South-Feb19 MoM-MHPSS TF-South-Jan19

2015	2016
MoM-MHPSS TF-South-5-Dec15 MoM-MHPSS TF-South-4-Nov15 MoM-MHPSS TF-South-3-Oct15 MoM-MHPSS TF-South-2-Sep15 MoM-MHPSS TF-South-1-Aug15	MoM-MHPSS TF-South-12-Oct16 MoM-MHPSS TF-South-11-Aug16 MoM-MHPSS TF-South-10-June16 MoM-MHPSS TF-South-9-May16 MoM-MHPSS TF-South-8-March16 MoM-MHPSS TF-South-7-Feb16 MoM-MHPSS TF-South-6-Jan16

Minutes of meetings